| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Monroe Terilyn J. | Chief People Officer | 3100 HANOVER STREET, PALO ALTO | /s/ John G. Saia, as attorney-in-fact for Tarilyn J. Monroe | 02 Dec 2025 | 0001652956 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GH | Common Stock | Options Exercise | $704,900 | +35,000 | +134% | $20.14 | 61,087 | 01 Dec 2025 | Direct | |
| transaction | GH | Common Stock | Options Exercise | $429,150 | +15,000 | +25% | $28.61 | 76,087 | 01 Dec 2025 | Direct | |
| transaction | GH | Common Stock | Sale | $1,956,610 | -18,576 | -24% | $105.33 | 57,511 | 01 Dec 2025 | Direct | F1 |
| transaction | GH | Common Stock | Sale | $2,544,840 | -23,974 | -42% | $106.15 | 33,537 | 01 Dec 2025 | Direct | F2 |
| transaction | GH | Common Stock | Sale | $725,423 | -6,786 | -20% | $106.90 | 26,751 | 01 Dec 2025 | Direct | F3 |
| transaction | GH | Common Stock | Sale | $71,612 | -664 | -2.5% | $107.85 | 26,087 | 01 Dec 2025 | Direct | F4 |
| transaction | GH | Common Stock | Sale | $202,550 | -1,923 | -7.4% | $105.33 | 24,164 | 01 Dec 2025 | Direct | F5 |
| transaction | GH | Common Stock | Sale | $259,504 | -2,444 | -10% | $106.18 | 21,720 | 01 Dec 2025 | Direct | F6 |
| transaction | GH | Common Stock | Sale | $85,624 | -800 | -3.7% | $107.03 | 20,920 | 01 Dec 2025 | Direct | F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GH | Stock Option (Right to Buy) | Options Exercise | $0 | -35,000 | -45% | $0.000000 | 43,204 | 01 Dec 2025 | Common Stock | 35,000 | $20.14 | Direct | F8 |
| transaction | GH | Stock Option (Right to Buy) | Options Exercise | $0 | -15,000 | -31% | $0.000000 | 32,627 | 01 Dec 2025 | Common Stock | 15,000 | $28.61 | Direct | F9 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.625 to $105.620. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F2 | Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.625 to $106.620. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F3 | Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.625 to $107.560. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F4 | Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.730 to $107.970. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F5 | Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.680 to $105.620. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F6 | Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.680 to $106.670. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F7 | Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.710 to $107.770. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F8 | This represents a stock option granted on February 26, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 2, 2025 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. |
| F9 | This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. |